COVIDTrach: a prospective cohort study of mechanically ventilated patients with COVID-19 undergoing tracheostomy in the UK

Abstract

Objectives: COVIDTrach is a UK multicentre prospective cohort study project that aims to evaluate the outcomes of tracheostomy in patients with COVID-19 receiving mechanical ventilation and record the incidence of SARS-CoV-2 infection among healthcare workers involved in the procedure.

Design: Data on patient demographic, clinical history and outcomes were entered prospectively and updated over time via an online database (REDCap). Clinical variables were compared with outcomes, with logistic regression used to develop a model for mortality. Participants recorded whether any operators tested positive for SARS-CoV-2 within 2 weeks of the procedure.

Setting: UK National Health Service departments involved in treating patients with COVID-19 receiving mechanical ventilation.

Participants: The cohort comprised 1605 tracheostomy cases from 126 UK hospitals collected between 6 April and 26 August 2020.

Main outcome measures: Mortality following tracheostomy, successful wean from mechanical ventilation and length of time from tracheostomy to wean, discharge from hospital, complications from tracheostomy, reported SARS-CoV-2 infection among operators.

Results: The median time from intubation to tracheostomy was 15 days (IQR 11, 21). 285 (18%) patients died following the procedure. 1229 (93%) of the survivors had been successfully weaned from mechanical ventilation at censoring and 1049 (81%) had been discharged from hospital. Age, inspired oxygen concentration, positive end-expiratory pressure setting, fever, number of days of ventilation before tracheostomy, C reactive protein and the use of anticoagulation and inotropic support independently predicted mortality. Six reports were received of operators testing positive for SARS-CoV-2 within 2 weeks of the procedure.

Conclusions: Tracheostomy appears to be safe in mechanically ventilated patients with COVID-19 and to operators performing the procedure and we identified clinical parameters that are predictive of mortality.

Trial registration number: The study is registered with ClinicalTrials.Gov (NCT04572438).

Keywords: Anaesthesiology Devices; COVID-19; cohort study; ear–nose–throat devices.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1

(A) Length of time from intubation to tracheostomy (days). (B) Number of tracheostomies divided by method and specialist performing the procedure. (C) Type of respirator used during the tracheostomy, x axis=total number of cases using that type of respirator. PARP; powered air-purifying respirator.

Figure 2

(A) ORs from multivariable logistic regression model for mortality (n=1566). Eight predictive clinical variables were identified. Days of ventilation, FiO2 and PEEP setting are presented using categories to aid interpretation. (B) ROC curve for multivariable prediction model. Internal validation using tenfold cross-validation produced an average ROC area of 0.75 (range: 0.64–0.87). (C) Observed and predicted risk for 10 quantile groups. The groups (1–10) were obtained by splitting patients by their predicted risk, that is, group 1 comprise the 10% of patients with the lowest predicted risk. (D). Regression coefficients from multiple regression model for time to wean success (n=1031). CRP, C reactive protein; FiO2, inspired oxygen concentration; NIV, non-invasive ventilation.